|
V51169
|
Vepsitamab (AMG-199)
|
2413453-53-7 |
Vepsitamab (AMG 199) is an anti-MUC17/CD3 BiTE antibody that can bind to CD3 on T cells and MUC17 expressed on tumor cells, mediate the pathway of tumor cells, and induce T cell activation and proliferation. |
|
V51166
|
Vibecotamab (XmAb14045)
|
2138442-13-2 |
Vibecotamab (XmAb14045) is a potent bipotent targeting CD123 and CD3 that stimulates T cell-mediated lethality of CD123-expressing cells. |
|
V51163
|
Voxalatamab (JNJ-63898081)
|
2411871-58-2 |
Voxalatamab (JNJ-63898081) is a bipotential IgG4 enhancer that binds PSMA and CD3 and has anti-neoplastic activity for use in van cancer research. |